Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Kühne

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 14, 2025
TH-302 (evofosfamide) monotherapy exerts anticancer activity in Ewing's sarcoma cells under hypoxiaMarie Kühne, Sabine Becker, Jürgen Sonnemann, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 21, 2016
Assessment of HDACi-Induced CytotoxicityLisa Marx-Blümel, Christian Marx, Marie Kühne, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
HDACi Delivery Systems Based on Cellulose Valproate NanoparticlesHenry Lindemann, Marie Kühne, Andreas Koschella, et al.
Journal of Cancer Research and Clinical Oncology|August 10, 2020
Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing's sarcoma cellsSophie L Kerschner-Morales, Marie Kühne, Sabine Becker, et al.
International Journal of Pharmaceutics|April 4, 2021
Biocompatible valproic acid-coupled nanoparticles attenuate lipopolysaccharide-induced inflammationMarie Kühne, Christian Kretzer, Henry Lindemann, et al.
Pharmaceutics|December 23, 2023
Dually Modified Cellulose as a Non-Viral Vector for the Delivery and Uptake of HDAC3 siRNAJuliana Hülsmann, Henry Lindemann, Jamila Wegener, et al.
Macromolecular Bioscience|April 7, 2020
Polysaccharide Nanoparticles Bearing HDAC Inhibitor as Nontoxic Nanocarrier for Drug DeliveryHenry Lindemann, Marie Kühne, Christian Grune, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 8, 2020
Biocompatible sulfated valproic acid-coupled polysaccharide-based nanocarriers with HDAC inhibitory activityMarie Kühne, Henry Lindemann, Christian Grune, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Analysis of HDACi-Coupled Nanoparticles: Opportunities and ChallengesMarie Kühne, Susanne Hofmann, Henry Lindemann, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 14, 2025
TH-302 (evofosfamide) monotherapy exerts anticancer activity in Ewing's sarcoma cells under hypoxiaMarie Kühne, Sabine Becker, Jürgen Sonnemann, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 21, 2016
Assessment of HDACi-Induced CytotoxicityLisa Marx-Blümel, Christian Marx, Marie Kühne, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
HDACi Delivery Systems Based on Cellulose Valproate NanoparticlesHenry Lindemann, Marie Kühne, Andreas Koschella, et al.
Journal of Cancer Research and Clinical Oncology|August 10, 2020
Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing's sarcoma cellsSophie L Kerschner-Morales, Marie Kühne, Sabine Becker, et al.
International Journal of Pharmaceutics|April 4, 2021
Biocompatible valproic acid-coupled nanoparticles attenuate lipopolysaccharide-induced inflammationMarie Kühne, Christian Kretzer, Henry Lindemann, et al.
Pharmaceutics|December 23, 2023
Dually Modified Cellulose as a Non-Viral Vector for the Delivery and Uptake of HDAC3 siRNAJuliana Hülsmann, Henry Lindemann, Jamila Wegener, et al.
Macromolecular Bioscience|April 7, 2020
Polysaccharide Nanoparticles Bearing HDAC Inhibitor as Nontoxic Nanocarrier for Drug DeliveryHenry Lindemann, Marie Kühne, Christian Grune, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 8, 2020
Biocompatible sulfated valproic acid-coupled polysaccharide-based nanocarriers with HDAC inhibitory activityMarie Kühne, Henry Lindemann, Christian Grune, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Analysis of HDACi-Coupled Nanoparticles: Opportunities and ChallengesMarie Kühne, Susanne Hofmann, Henry Lindemann, et al.
Pageof 1